Evidence map›Paper›PMID 41640645›Full record

ArticleAdvanced biomedical research2025

Treatment-resistant Inflammatory Demyelinating Pseudotumor with Marburg-Like Features: A Rare Case Report.

Mohammad Amin Najafi, Payam Riahi, Shakiba Houshi, Samira Kazemi, Somayeh Haji Ahmadi, Parvin Mahzouni, Salar Nasr, Mohammad Reza Najafi

Abstract readCase Reports
In one paragraph

Article in Advanced biomedical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mohammad Amin NajafiDepartment of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Payam RiahiDepartment of Radiology, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Shakiba HoushiDepartment of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Samira KazemiDepartment of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Somayeh Haji AhmadiDepartment of Radiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Parvin MahzouniDepartment of Pathology, Alzahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Salar NasrDepartment of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Mohammad Reza NajafiDepartment of Neurology, Alzahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory demyelinating pseudotumors (IDPs), also known as tumor-like demyelinating lesions, are rare conditions that mimic intracranial neoplasms, presenting significant diagnostic challenges. The Marburg variant of multiple sclerosis (MS), an aggressive form of demyelinating disease, can present with IDP, further complicating diagnosis. We report the case of a 51-year-old male who developed progressive neurological deficits over one month. Brain MRI revealed bilateral supra- and infratentorial lesions, initially raising suspicion of both demyelinating disease and neoplastic processes. Extensive investigations, including spinal MRI, cerebrospinal fluid (CSF) analysis, and stereotactic biopsy, confirmed a diagnosis of IDP with Marburg-like features. Although initial improvement was achieved by high-dose corticosteroids and plasma exchange, the patient was worsened. The patient was a candidate for high-dose cyclophosphamide. This case underscores the importance of distinguishing IDP from aggressive demyelinating diseases such as Marburg MS, emphasizing the role of biopsy for definitive diagnosis and the critical need for prompt aggressive immunosuppressive therapy. Ultimately, the patient did not consent to initiating the cyclophosphamide pulse and left the hospital against medical advice. Unfortunately, the patient passed away approximately one month later.

Indexed as

Brain biopsycyclophosphamideMarburg variantMRIrituximabtumefactive demyelinating lesion

Identifiers

PMID41640645
PMCPMC12867192

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.